New Haven Register (Connecticut) published the following article: “End Conflicts on FDA Approvals,” which reports, “In the coming weeks, the U.S. House and Senate will have to reconcile bills they passed that give the Food and Drug Administration (FDA) more money and authority to guarantee the safety of prescription drugs. The legislation is needed. There have been repeated instances where unsafe drugs have remained on the market and safety concerns of FDA scientists have been ignored.” The article recommends that the conference committee that resolves the differences between the House and Senate versions of the bill should keep the House amendment that eliminates financial conflicts of interest of members of the FDA advisory committees that vote on drug safety.
article link

0 Comments